Other Cancers

7 protocols meet the specified criteria.

  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

  • COG-AGCT1531

    A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)

  • GRAIL-MA-001

    REFLECTION: Real World Evidence for Learnings in Early Cancer Detection, a Clinical Practice Learning Program for Galleri

  • S2012

    Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)

  • S2013

    Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

  • XPORT-MF-034

    A Phase 1 / Phase 3 Study to Evaluate the Efficacy and Safety of Selinexor, A Selective Inhibitor of Nuclear Export, in Combination with Ruxolitinib in Treatment-Naïve Patients with Myelofibrosis